23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Sino Biopharmaceutical Limited › 2025-2026

Sino Biopharmaceutical Limited 2025-2026 Proxy Voting Records

At Sino Biopharmaceutical Limited's shareholder meeting held June 17, 2026, in the 2025-2026 proxy season, 60 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,183 separate fund positions. Their filings are grouped here into 27 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — Accept Financial Statements and Statutory Reports — the reporting funds cast 100% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings. Page generated November 8, 2026.

  • 27Reported items
  • 60Asset managers
  • 1,183Fund votes
  • June 17, 2026Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from Sino Biopharmaceutical Limited has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2025-2026

Explore Sino Biopharmaceutical Limited in the interactive database Compare manager voting policies

How asset managers voted at the Sino Biopharmaceutical Limited 2025-2026 meeting

Each item below shows how the 60 asset managers that disclosed a Sino Biopharmaceutical Limited vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Sino Biopharmaceutical Limited’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Cheng Cheung Ling as Director

No official resultsDIRECTOR ELECTIONS

99.8% of fund votes cast · no official result

FOR
Details: votes by 41 asset managers

The 41 asset managers below reported 690,208,664 for, 942,130 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 690,208,664AGAINST: 942,130
Largest asset managers voting on “Elect Cheng Cheung Ling as Director” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard310,327,2300 00For
BlackRock194,415,4010 00For
Fidelity53,652,1020 00For
State Street27,946,5000 00For
American Century24,002,5000 00For
AllianceBernstein19,645,0000 00For
TIAA10,971,8170 00For
Dimensional10,703,5000 00For
Pacific Life5,143,0000 00For
Lazard3,723,0000 00For
WisdomTree3,644,1500 00For
Brighthouse3,128,0000 00For
Northern Trust2,390,7490 00For
Columbia Threadneedle2,290,0000 00For
Goldman Sachs2,090,8710 00For
Eaton Vance1,898,2500 00For
FRANKLIN FUND ALLOCATOR SERIES1,603,0000 00For
AQR1,460,0000 00For
AIG/SunAmerica1,351,7500 00For
ADVISORS' INNER CIRCLE FUND1,303,0000 00For
MASTER INVESTMENT PORTFOLIO1,188,7500 00For
Victory Capital1,081,6140 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,078,0000 00For
Voya1,072,0000 00For
Franklin Templeton972,0000 00For

Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).

2. Elect Lu Zhengfei as Director

No official resultsDIRECTOR ELECTIONS

71% of fund votes cast · no official result

FORAGAINST
Details: votes by 41 asset managers

The 41 asset managers below reported 490,483,263 for, 200,667,531 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 490,483,263AGAINST: 200,667,531
Largest asset managers voting on “Elect Lu Zhengfei as Director” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard310,327,2300 00For
BlackRock145,000194,270,401 00Against
Fidelity53,652,1020 00For
State Street27,946,5000 00For
American Century24,002,5000 00For
AllianceBernstein19,645,0000 00For
TIAA10,971,8170 00For
Dimensional10,703,5000 00For
Pacific Life5,143,0000 00For
Lazard3,723,0000 00For
WisdomTree3,644,1500 00For
Brighthouse3,128,0000 00For
Northern Trust2,390,7490 00For
Columbia Threadneedle02,290,000 00Against
Goldman Sachs2,090,8710 00For
Eaton Vance01,898,250 00Against
FRANKLIN FUND ALLOCATOR SERIES1,603,0000 00For
AQR1,460,0000 00For
AIG/SunAmerica1,351,7500 00For
ADVISORS' INNER CIRCLE FUND1,303,0000 00For
MASTER INVESTMENT PORTFOLIO545,000643,750 00Mixed
Victory Capital1,081,6140 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,078,0000 00For
Voya1,072,0000 00For
Franklin Templeton972,0000 00For

Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).

3. TO RE-ELECT MR. LU ZHENGFEI AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR OF THE COMPANY

No official resultsDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

27% of fund votes cast · no official result

FORAGAINST
Details: votes by 11 asset managers

The 11 asset managers below reported 4,951,698 for, 13,321,901 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 4,951,698AGAINST: 13,321,901
Largest asset managers voting on “TO RE-ELECT MR. LU ZHENGFEI AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR OF THE COMPANY” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock06,835,151 00Against
Krane Shares Trust04,078,750 00Against
John Hancock2,632,6600 00For
Touchstone ETF Trust02,225,000 00Against
Jackson National983,5000 00For
Advisors' Inner Circle Fund III531,0430 00For
GPS Funds I333,9380 00For
SP Funds Trust200,5210 00For
WILSHIRE MUTUAL FUNDS INC0183,000 00Against
Rayliant Funds Trust147,0360 00For
Innovator ETFs Trust123,0000 00For

4. TO RE-ELECT MS. CHENG CHEUNG LING AS AN EXECUTIVE DIRECTOR OF THE COMPANY

No official resultsDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 11 asset managers

The 11 asset managers below reported 18,273,599 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 18,273,599
Largest asset managers voting on “TO RE-ELECT MS. CHENG CHEUNG LING AS AN EXECUTIVE DIRECTOR OF THE COMPANY” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock6,835,1510 00For
Krane Shares Trust4,078,7500 00For
John Hancock2,632,6600 00For
Touchstone ETF Trust2,225,0000 00For
Jackson National983,5000 00For
Advisors' Inner Circle Fund III531,0430 00For
GPS Funds I333,9380 00For
SP Funds Trust200,5210 00For
WILSHIRE MUTUAL FUNDS INC183,0000 00For
Rayliant Funds Trust147,0360 00For
Innovator ETFs Trust123,0000 00For

5. Elect CHENG Cheung Ling

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 10 asset managers

The 10 asset managers below reported 34,618,688 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 34,618,688
Largest asset managers voting on “Elect CHENG Cheung Ling” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab17,646,5830 00For
Hartford7,344,2800 00For
Mercer Funds2,973,0000 00For
Russell Investments2,924,0000 00For
GUINNESS ATKINSON FUNDS1,525,5000 00For
SEI Exchange Traded Funds1,039,2200 00For
Goldman Sachs657,9000 00For
Venerable Variable Insurance Trust353,0000 00For
SEI136,2050 00For
Man ETF Series Trust19,0000 00For

6. Elect LU Zhengfei

No official resultsDIRECTOR ELECTIONS

9% of fund votes cast · no official result

AGAINST
Details: votes by 10 asset managers

The 10 asset managers below reported 2,973,000 for, 31,645,688 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,973,000AGAINST: 31,645,688
Largest asset managers voting on “Elect LU Zhengfei” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab017,646,583 00Against
Hartford07,344,280 00Against
Mercer Funds2,973,0000 00For
Russell Investments02,924,000 00Against
GUINNESS ATKINSON FUNDS01,525,500 00Against
SEI Exchange Traded Funds01,039,220 00Against
Goldman Sachs0657,900 00Against
Venerable Variable Insurance Trust0353,000 00Against
SEI0136,205 00Against
Man ETF Series Trust019,000 00Against

7. Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights

No official resultsCAPITAL STRUCTURE

45% of fund votes cast · no official result

FORAGAINST
Details: votes by 41 asset managers

The 41 asset managers below reported 310,825,230 for, 380,325,564 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 310,825,230AGAINST: 380,325,564
Largest asset managers voting on “Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard310,327,2300 00For
BlackRock0194,415,401 00Against
Fidelity053,652,102 00Against
State Street027,946,500 00Against
American Century024,002,500 00Against
AllianceBernstein019,645,000 00Against
TIAA010,971,817 00Against
Dimensional010,703,500 00Against
Pacific Life05,143,000 00Against
Lazard03,723,000 00Against
WisdomTree03,644,150 00Against
Brighthouse03,128,000 00Against
Northern Trust02,390,749 00Against
Columbia Threadneedle02,290,000 00Against
Goldman Sachs02,090,871 00Against
Eaton Vance01,898,250 00Against
FRANKLIN FUND ALLOCATOR SERIES01,603,000 00Against
AQR01,460,000 00Against
AIG/SunAmerica01,351,750 00Against
ADVISORS' INNER CIRCLE FUND01,303,000 00Against
MASTER INVESTMENT PORTFOLIO01,188,750 00Against
Victory Capital01,081,614 00Against
PROFESSIONALLY MANAGED PORTFOLIOS01,078,000 00Against
Voya01,072,000 00Against
Franklin Templeton0972,000 00Against

Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).

8. Authorize Reissuance of Repurchased Shares

No official resultsCAPITAL STRUCTURE

45.1% of fund votes cast · no official result

FORAGAINST
Details: votes by 41 asset managers

The 41 asset managers below reported 311,903,230 for, 379,247,564 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 311,903,230AGAINST: 379,247,564
Largest asset managers voting on “Authorize Reissuance of Repurchased Shares” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard310,327,2300 00For
BlackRock0194,415,401 00Against
Fidelity053,652,102 00Against
State Street027,946,500 00Against
American Century024,002,500 00Against
AllianceBernstein019,645,000 00Against
TIAA010,971,817 00Against
Dimensional010,703,500 00Against
Pacific Life05,143,000 00Against
Lazard03,723,000 00Against
WisdomTree03,644,150 00Against
Brighthouse03,128,000 00Against
Northern Trust02,390,749 00Against
Columbia Threadneedle02,290,000 00Against
Goldman Sachs02,090,871 00Against
Eaton Vance01,898,250 00Against
FRANKLIN FUND ALLOCATOR SERIES01,603,000 00Against
AQR01,460,000 00Against
AIG/SunAmerica01,351,750 00Against
ADVISORS' INNER CIRCLE FUND01,303,000 00Against
MASTER INVESTMENT PORTFOLIO01,188,750 00Against
Victory Capital01,081,614 00Against
PROFESSIONALLY MANAGED PORTFOLIOS1,078,0000 00For
Voya01,072,000 00Against
Franklin Templeton0972,000 00Against

Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).

9. Authorize Repurchase of Issued Share Capital

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: votes by 41 asset managers

The 41 asset managers below reported 691,150,794 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 691,150,794
Largest asset managers voting on “Authorize Repurchase of Issued Share Capital” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard310,327,2300 00For
BlackRock194,415,4010 00For
Fidelity53,652,1020 00For
State Street27,946,5000 00For
American Century24,002,5000 00For
AllianceBernstein19,645,0000 00For
TIAA10,971,8170 00For
Dimensional10,703,5000 00For
Pacific Life5,143,0000 00For
Lazard3,723,0000 00For
WisdomTree3,644,1500 00For
Brighthouse3,128,0000 00For
Northern Trust2,390,7490 00For
Columbia Threadneedle2,290,0000 00For
Goldman Sachs2,090,8710 00For
Eaton Vance1,898,2500 00For
FRANKLIN FUND ALLOCATOR SERIES1,603,0000 00For
AQR1,460,0000 00For
AIG/SunAmerica1,351,7500 00For
ADVISORS' INNER CIRCLE FUND1,303,0000 00For
MASTER INVESTMENT PORTFOLIO1,188,7500 00For
Victory Capital1,081,6140 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,078,0000 00For
Voya1,072,0000 00For
Franklin Templeton972,0000 00For

Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).

10. To extend the general mandate to allot, issue and otherwise deal with additional shares under resolution 7(A) by the…

No official resultsCAPITAL STRUCTURE

5% of fund votes cast · no official result

AGAINST
Details: description as filed, votes by 11 asset managers

Description as filed by funds: TO EXTEND THE GENERAL MANDATE TO ALLOT, ISSUE AND OTHERWISE DEAL WITH ADDITIONAL SHARES UNDER RESOLUTION 7(A) BY THE ADDITION THERETO OF SUCH NUMBER OF SHARES BOUGHT BACK BY THE COMPANY UNDER RESOLUTION 7(B)

The 11 asset managers below reported 878,600 for, 17,394,999 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 878,600AGAINST: 17,394,999
Largest asset managers voting on “TO EXTEND THE GENERAL MANDATE TO ALLOT, ISSUE AND OTHERWISE DEAL WITH ADDITIONAL SHARES UNDER RESOLUTION 7(A) ” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock06,835,151 00Against
Krane Shares Trust04,078,750 00Against
John Hancock02,632,660 00Against
Touchstone ETF Trust02,225,000 00Against
Jackson National0983,500 00Against
Advisors' Inner Circle Fund III531,0430 00For
GPS Funds I0333,938 00Against
SP Funds Trust200,5210 00For
WILSHIRE MUTUAL FUNDS INC0183,000 00Against
Rayliant Funds Trust147,0360 00For
Innovator ETFs Trust0123,000 00Against

11. Authority to Issue Repurchased Shares

No official resultsCAPITAL STRUCTURE

0% of fund votes cast · no official result

AGAINST
Details: votes by 10 asset managers

The 10 asset managers below reported 34,618,688 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

AGAINST: 34,618,688
Largest asset managers voting on “Authority to Issue Repurchased Shares” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab017,646,583 00Against
Hartford07,344,280 00Against
Mercer Funds02,973,000 00Against
Russell Investments02,924,000 00Against
GUINNESS ATKINSON FUNDS01,525,500 00Against
SEI Exchange Traded Funds01,039,220 00Against
Goldman Sachs0657,900 00Against
Venerable Variable Insurance Trust0353,000 00Against
SEI0136,205 00Against
Man ETF Series Trust019,000 00Against

12. Authority to Issue Shares w/o Preemptive Rights

No official resultsCAPITAL STRUCTURE

0% of fund votes cast · no official result

AGAINST
Details: votes by 10 asset managers

The 10 asset managers below reported 34,618,688 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

AGAINST: 34,618,688
Largest asset managers voting on “Authority to Issue Shares w/o Preemptive Rights” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab017,646,583 00Against
Hartford07,344,280 00Against
Mercer Funds02,973,000 00Against
Russell Investments02,924,000 00Against
GUINNESS ATKINSON FUNDS01,525,500 00Against
SEI Exchange Traded Funds01,039,220 00Against
Goldman Sachs0657,900 00Against
Venerable Variable Insurance Trust0353,000 00Against
SEI0136,205 00Against
Man ETF Series Trust019,000 00Against

13. Authority to Repurchase Shares

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: votes by 10 asset managers

The 10 asset managers below reported 34,618,688 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 34,618,688
Largest asset managers voting on “Authority to Repurchase Shares” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab17,646,5830 00For
Hartford7,344,2800 00For
Mercer Funds2,973,0000 00For
Russell Investments2,924,0000 00For
GUINNESS ATKINSON FUNDS1,525,5000 00For
SEI Exchange Traded Funds1,039,2200 00For
Goldman Sachs657,9000 00For
Venerable Variable Insurance Trust353,0000 00For
SEI136,2050 00For
Man ETF Series Trust19,0000 00For

14. To Grant to the directors a general mandate to allot, issue and otherwise deal with additional shares not exceeding 20%…

No official resultsCAPITAL STRUCTURE

5% of fund votes cast · no official result

AGAINST
Details: description as filed, votes by 10 asset managers

Description as filed by funds: TO GRANT TO THE DIRECTORS A GENERAL MANDATE TO ALLOT, ISSUE AND OTHERWISE DEAL WITH ADDITIONAL SHARES NOT EXCEEDING 20% OF THE ISSUED SHARE CAPITAL OF THE COMPANY

The 10 asset managers below reported 878,600 for, 15,169,999 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 878,600AGAINST: 15,169,999
Largest asset managers voting on “TO GRANT TO THE DIRECTORS A GENERAL MANDATE TO ALLOT, ISSUE AND OTHERWISE DEAL WITH ADDITIONAL SHARES NOT EXCE” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock06,835,151 00Against
Krane Shares Trust04,078,750 00Against
John Hancock02,632,660 00Against
Jackson National0983,500 00Against
Advisors' Inner Circle Fund III531,0430 00For
GPS Funds I0333,938 00Against
SP Funds Trust200,5210 00For
WILSHIRE MUTUAL FUNDS INC0183,000 00Against
Rayliant Funds Trust147,0360 00For
Innovator ETFs Trust0123,000 00Against

15. To Grant to the directors a general mandate to BUY back shares not exceeding 10% of the issued share capital of the…

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 10 asset managers

Description as filed by funds: TO GRANT TO THE DIRECTORS A GENERAL MANDATE TO BUY BACK SHARES NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY

The 10 asset managers below reported 16,048,599 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 16,048,599
Largest asset managers voting on “TO GRANT TO THE DIRECTORS A GENERAL MANDATE TO BUY BACK SHARES NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL O” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock6,835,1510 00For
Krane Shares Trust4,078,7500 00For
John Hancock2,632,6600 00For
Jackson National983,5000 00For
Advisors' Inner Circle Fund III531,0430 00For
GPS Funds I333,9380 00For
SP Funds Trust200,5210 00For
WILSHIRE MUTUAL FUNDS INC183,0000 00For
Rayliant Funds Trust147,0360 00For
Innovator ETFs Trust123,0000 00For

16. Accept Financial Statements and Statutory Reports

No official resultsCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: votes by 41 asset managers

The 41 asset managers below reported 691,150,794 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 691,150,794
Largest asset managers voting on “Accept Financial Statements and Statutory Reports” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard310,327,2300 00For
BlackRock194,415,4010 00For
Fidelity53,652,1020 00For
State Street27,946,5000 00For
American Century24,002,5000 00For
AllianceBernstein19,645,0000 00For
TIAA10,971,8170 00For
Dimensional10,703,5000 00For
Pacific Life5,143,0000 00For
Lazard3,723,0000 00For
WisdomTree3,644,1500 00For
Brighthouse3,128,0000 00For
Northern Trust2,390,7490 00For
Columbia Threadneedle2,290,0000 00For
Goldman Sachs2,090,8710 00For
Eaton Vance1,898,2500 00For
FRANKLIN FUND ALLOCATOR SERIES1,603,0000 00For
AQR1,460,0000 00For
AIG/SunAmerica1,351,7500 00For
ADVISORS' INNER CIRCLE FUND1,303,0000 00For
MASTER INVESTMENT PORTFOLIO1,188,7500 00For
Victory Capital1,081,6140 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,078,0000 00For
Voya1,072,0000 00For
Franklin Templeton972,0000 00For

Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).

17. Approve Final Dividend

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: votes by 41 asset managers

The 41 asset managers below reported 691,150,794 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 691,150,794
Largest asset managers voting on “Approve Final Dividend” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard310,327,2300 00For
BlackRock194,415,4010 00For
Fidelity53,652,1020 00For
State Street27,946,5000 00For
American Century24,002,5000 00For
AllianceBernstein19,645,0000 00For
TIAA10,971,8170 00For
Dimensional10,703,5000 00For
Pacific Life5,143,0000 00For
Lazard3,723,0000 00For
WisdomTree3,644,1500 00For
Brighthouse3,128,0000 00For
Northern Trust2,390,7490 00For
Columbia Threadneedle2,290,0000 00For
Goldman Sachs2,090,8710 00For
Eaton Vance1,898,2500 00For
FRANKLIN FUND ALLOCATOR SERIES1,603,0000 00For
AQR1,460,0000 00For
AIG/SunAmerica1,351,7500 00For
ADVISORS' INNER CIRCLE FUND1,303,0000 00For
MASTER INVESTMENT PORTFOLIO1,188,7500 00For
Victory Capital1,081,6140 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,078,0000 00For
Voya1,072,0000 00For
Franklin Templeton972,0000 00For

Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).

18. Accounts and Reports

No official resultsCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: votes by 10 asset managers

The 10 asset managers below reported 34,618,688 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 34,618,688
Largest asset managers voting on “Accounts and Reports” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab17,646,5830 00For
Hartford7,344,2800 00For
Mercer Funds2,973,0000 00For
Russell Investments2,924,0000 00For
GUINNESS ATKINSON FUNDS1,525,5000 00For
SEI Exchange Traded Funds1,039,2200 00For
Goldman Sachs657,9000 00For
Venerable Variable Insurance Trust353,0000 00For
SEI136,2050 00For
Man ETF Series Trust19,0000 00For

19. Allocation of Profits/Dividends

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: votes by 10 asset managers

The 10 asset managers below reported 34,618,688 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 34,618,688
Largest asset managers voting on “Allocation of Profits/Dividends” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab17,646,5830 00For
Hartford7,344,2800 00For
Mercer Funds2,973,0000 00For
Russell Investments2,924,0000 00For
GUINNESS ATKINSON FUNDS1,525,5000 00For
SEI Exchange Traded Funds1,039,2200 00For
Goldman Sachs657,9000 00For
Venerable Variable Insurance Trust353,0000 00For
SEI136,2050 00For
Man ETF Series Trust19,0000 00For

20. To declare payment of a final dividend for the year ended 31 December 2025

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 10 asset managers

Description as filed by funds: TO DECLARE PAYMENT OF A FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025

The 10 asset managers below reported 16,048,599 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 16,048,599
Largest asset managers voting on “TO DECLARE PAYMENT OF A FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock6,835,1510 00For
Krane Shares Trust4,078,7500 00For
John Hancock2,632,6600 00For
Jackson National983,5000 00For
Advisors' Inner Circle Fund III531,0430 00For
GPS Funds I333,9380 00For
SP Funds Trust200,5210 00For
WILSHIRE MUTUAL FUNDS INC183,0000 00For
Rayliant Funds Trust147,0360 00For
Innovator ETFs Trust123,0000 00For

21. Authorize Board to Fix Remuneration of Directors

97% of fund votes cast · no official result

FOR
Details: votes by 41 asset managers

The 41 asset managers below reported 671,421,082 for, 19,729,712 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 671,421,082AGAINST: 19,729,712
Largest asset managers voting on “Authorize Board to Fix Remuneration of Directors” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard310,327,2300 00For
BlackRock194,415,4010 00For
Fidelity53,652,1020 00For
State Street27,946,5000 00For
American Century24,002,5000 00For
AllianceBernstein019,645,000 00Against
TIAA10,971,8170 00For
Dimensional10,703,5000 00For
Pacific Life5,143,0000 00For
Lazard3,723,0000 00For
WisdomTree3,644,1500 00For
Brighthouse3,128,0000 00For
Northern Trust2,390,7490 00For
Columbia Threadneedle2,290,0000 00For
Goldman Sachs2,090,8710 00For
Eaton Vance1,898,2500 00For
FRANKLIN FUND ALLOCATOR SERIES1,603,0000 00For
AQR1,460,0000 00For
AIG/SunAmerica1,351,7500 00For
ADVISORS' INNER CIRCLE FUND1,303,0000 00For
MASTER INVESTMENT PORTFOLIO1,188,7500 00For
Victory Capital1,081,6140 00For
PROFESSIONALLY MANAGED PORTFOLIOS1,078,0000 00For
Voya1,072,0000 00For
Franklin Templeton972,0000 00For

Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).

22. To authorise the board of directors to fix the remuneration of the directors

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 11 asset managers

Description as filed by funds: TO AUTHORISE THE BOARD OF DIRECTORS TO FIX THE REMUNERATION OF THE DIRECTORS

The 11 asset managers below reported 18,273,599 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 18,273,599
Largest asset managers voting on “TO AUTHORISE THE BOARD OF DIRECTORS TO FIX THE REMUNERATION OF THE DIRECTORS” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock6,835,1510 00For
Krane Shares Trust4,078,7500 00For
John Hancock2,632,6600 00For
Touchstone ETF Trust2,225,0000 00For
Jackson National983,5000 00For
Advisors' Inner Circle Fund III531,0430 00For
GPS Funds I333,9380 00For
SP Funds Trust200,5210 00For
WILSHIRE MUTUAL FUNDS INC183,0000 00For
Rayliant Funds Trust147,0360 00For
Innovator ETFs Trust123,0000 00For

23. Directors' Fees

100% of fund votes cast · no official result

FOR
Details: votes by 10 asset managers

The 10 asset managers below reported 34,618,688 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 34,618,688
Largest asset managers voting on “Directors' Fees” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab17,646,5830 00For
Hartford7,344,2800 00For
Mercer Funds2,973,0000 00For
Russell Investments2,924,0000 00For
GUINNESS ATKINSON FUNDS1,525,5000 00For
SEI Exchange Traded Funds1,039,2200 00For
Goldman Sachs657,9000 00For
Venerable Variable Insurance Trust353,0000 00For
SEI136,2050 00For
Man ETF Series Trust19,0000 00For

24. Approve Ernst & Young as Auditors and Authorize Board to Fix Their Remuneration

No official resultsAUDIT-RELATED

99.8% of fund votes cast · no official result

FOR
Details: votes by 41 asset managers

The 41 asset managers below reported 690,072,794 for, 1,078,000 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 690,072,794AGAINST: 1,078,000
Largest asset managers voting on “Approve Ernst & Young as Auditors and Authorize Board to Fix Their Remuneration” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard310,327,2300 00For
BlackRock194,415,4010 00For
Fidelity53,652,1020 00For
State Street27,946,5000 00For
American Century24,002,5000 00For
AllianceBernstein19,645,0000 00For
TIAA10,971,8170 00For
Dimensional10,703,5000 00For
Pacific Life5,143,0000 00For
Lazard3,723,0000 00For
WisdomTree3,644,1500 00For
Brighthouse3,128,0000 00For
Northern Trust2,390,7490 00For
Columbia Threadneedle2,290,0000 00For
Goldman Sachs2,090,8710 00For
Eaton Vance1,898,2500 00For
FRANKLIN FUND ALLOCATOR SERIES1,603,0000 00For
AQR1,460,0000 00For
AIG/SunAmerica1,351,7500 00For
ADVISORS' INNER CIRCLE FUND1,303,0000 00For
MASTER INVESTMENT PORTFOLIO1,188,7500 00For
Victory Capital1,081,6140 00For
PROFESSIONALLY MANAGED PORTFOLIOS01,078,000 00Against
Voya1,072,0000 00For
Franklin Templeton972,0000 00For

Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).

25. Appointment of Auditor and Authority to Set Fees

No official resultsAUDIT-RELATED

96% of fund votes cast · no official result

FOR
Details: votes by 10 asset managers

The 10 asset managers below reported 33,093,188 for, 1,525,500 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 33,093,188AGAINST: 1,525,500
Largest asset managers voting on “Appointment of Auditor and Authority to Set Fees” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab17,646,5830 00For
Hartford7,344,2800 00For
Mercer Funds2,973,0000 00For
Russell Investments2,924,0000 00For
GUINNESS ATKINSON FUNDS01,525,500 00Against
SEI Exchange Traded Funds1,039,2200 00For
Goldman Sachs657,9000 00For
Venerable Variable Insurance Trust353,0000 00For
SEI136,2050 00For
Man ETF Series Trust19,0000 00For

26. To re-appoint Ernst and Young as auditors for the year ending 31 December 2026 and to authorise the board of directors…

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 10 asset managers

Description as filed by funds: TO RE-APPOINT ERNST AND YOUNG AS AUDITORS FOR THE YEAR ENDING 31 DECEMBER 2026 AND TO AUTHORISE THE BOARD OF DIRECTORS TO FIX THEIR REMUNERATION

The 10 asset managers below reported 16,048,599 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 16,048,599
Largest asset managers voting on “TO RE-APPOINT ERNST AND YOUNG AS AUDITORS FOR THE YEAR ENDING 31 DECEMBER 2026 AND TO AUTHORISE THE BOARD OF D” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock6,835,1510 00For
Krane Shares Trust4,078,7500 00For
John Hancock2,632,6600 00For
Jackson National983,5000 00For
Advisors' Inner Circle Fund III531,0430 00For
GPS Funds I333,9380 00For
SP Funds Trust200,5210 00For
WILSHIRE MUTUAL FUNDS INC183,0000 00For
Rayliant Funds Trust147,0360 00For
Innovator ETFs Trust123,0000 00For

27. To receive and adopt the audited consolidated financial statements of the company, the report of the directors of the…

No official resultsCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 10 asset managers

Description as filed by funds: TO RECEIVE AND ADOPT THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY, THE REPORT OF THE DIRECTORS OF THE COMPANY (DIRECTORS) AND THE REPORT OF THE INDEPENDENT AUDITORS OF THE COMPANY (AUDITORS) FOR THE YEAR ENDED 31 DECEMBER 2025

The 10 asset managers below reported 16,048,599 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 16,048,599
Largest asset managers voting on “TO RECEIVE AND ADOPT THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY, THE REPORT OF THE DIRECTORS” at Sino Biopharmaceutical Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock6,835,1510 00For
Krane Shares Trust4,078,7500 00For
John Hancock2,632,6600 00For
Jackson National983,5000 00For
Advisors' Inner Circle Fund III531,0430 00For
GPS Funds I333,9380 00For
SP Funds Trust200,5210 00For
WILSHIRE MUTUAL FUNDS INC183,0000 00For
Rayliant Funds Trust147,0360 00For
Innovator ETFs Trust123,0000 00For

Largest Sino Biopharmaceutical Limited shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.

Fund voting reports: top Sino Biopharmaceutical Limited shareholders by shares voted on “Accept Financial Statements and Statutory Reports”, 2025-2026
#Asset manager Shares voted
1Vanguard 310,327,230
2BlackRock 194,415,401
3Fidelity 53,652,102
4State Street 27,946,500
5American Century 24,002,500
6AllianceBernstein 19,645,000
7TIAA 10,971,817
8Dimensional 10,703,500
9Pacific Life 5,143,000
10Lazard 3,723,000

Shown as share counts, not percentages: no shares-outstanding figure has been matched to Sino Biopharmaceutical Limited for the 2025-2026 season, so there is no denominator to divide by.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

Sino Biopharmaceutical Limited proxy season coverage: 2025-2026 (this page).

Cite this page

proxyvotesnow.com, “Sino Biopharmaceutical Limited 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/sino-biopharmaceutical-limited/2026 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.